Ceforiz-T 1.125gm Injection
Marketer
Alester Pharma Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceforiz-T 1.125gm Injection
Ceftizoxime 1.125g injection, a dual-action formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be under medical guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation compromises efficacy. Common side effects may include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Follow-up laboratory and diagnostic tests may be requested to assess treatment response.
Uses of Ceforiz-T 1.125gm Injection
Infections caused by bacteria
Major Benefits of Ceforiz-T 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ceforiz-T 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceforiz-T 1.125gm Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ceforiz-T 1.125gm Injection works:
Ceftriaxone and Tazobactum, combined as Ceforiz-T 1.125gm Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ceforiz-T 1.125gm Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceforiz-T, 1.125gm, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Ceforiz-T 1.125gm Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceforiz-T 1.125gm Injection can induce drowsiness, visual disturbances, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceforiz-T 1.125gm Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ceforiz-T 1.125gm Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Ceforiz-T 1.125gm Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceforiz-T 1.125gm Injection :
Omitting a scheduled dose of Ceforiz-T 1.125gm Injection necessitates contacting your physician.
Facts to Know About Ceforiz-T 1.125gm Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Drugs to combat infection |
3,018 People bought this recently